Back
HFA Premium Access

Impact of eligibility to a randomized controlled trial in prognosis after Mitraclip implantation

Session: Heart Failure ePosters - focus on Valvular Heart Disease & Interventional Cardiology
Topic: Intervention
Speaker: Doctor G. Silva (Vila Nova de Gaia, PT)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Gualter Silva

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
2 presentations
0 follower

20 more presentations in this session

Additive value of soluble ST2 to NT-proBNP for more accurate patient risk stratification and long-term survival prediction after TAVI

Speaker: Miss A. Moya (Aalst, BE)

Access
Abstract
Slides
Like
Thumbnail

Left ventricular filling pressure as a determinant of risk stratification in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor K. Byczkowska (Warsaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Assessment left atrial geometry and function by cardiac magnetic resonance imaging in aortic stenosis

Speaker: Associate Professor L. Agoston Coldea (Cluj Napoca, RO)

Access
Abstract
Slides
Like
Thumbnail

Endocarditis: who are the true bad boys?

Speaker: Doctor P. Alves da Silva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Long-term prognostic implications of inflammatory and nutritional status in patients undergoing valvular heart surgery

Speaker: Miss D. Hung (Hong Kong, HK)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart Failure ePosters - focus on Valvular Heart Disease & Interventional Cardiology

Speakers: Doctor G. Silva, Miss A. Moya, Doctor K. Byczkowska, Associate Professor L. Agoston Coldea, Doctor P. Alves da Silva...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources